Skip to main content
logo
Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.065
-0.095 (-4.40%)
Aug 20, 2026, 10:34 AM EDT - Market open

Palisade Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.5--0.25--
Revenue Growth
------
Gross Profit
0.5--0.25--
Operating Income
-35.35-18.06-14.86-12.85-15.31-11.74
Net Income
-31.94-16.78-14.44-12.32-14.55-26.62
Earnings Per Share
-0.20-0.30-10.19-27.01-247.95-2546.13
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
125.17133.399.8212.4312.3810.5
Total Debt
-0.070.170.370.40.2
Net Cash (Debt)
125.17133.319.6512.0611.9810.3
Net Cash Growth
2358.69%1281.21%-19.99%0.70%16.35%-
Net Cash Per Share
0.792.396.8126.45204.12826.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-18.19-10.85-12.19-11.13-13.36-14.77
Capital Expenditures
----0-0.01-
Free Cash Flow
-18.19-10.85-12.19-11.14-13.37-14.77
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%--100.00%--
Operating Margin
-7069.80%---5138.00%--
Pretax Margin
-6388.20%---4920.00%--
Profit Margin
-6388.20%---4926.40%--
FCF Margin
-3638.00%---4454.80%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
719.74--21.88--